Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

Jianneng Li(Cleveland Clinic Lerner College of Medicine), Nima Sharifi(Sylvester Comprehensive Cancer Center)
eLife
February 12, 2017
Cited by 125


Related Papers